IEC 62304-compliant development, risk management, and submission-ready documentation — for SaMD that clears FDA review and holds up in the field.
We build Software as a Medical Device for diagnostic, monitoring, and clinical decision-support applications. IEC 62304 lifecycle discipline, ISO 14971 risk management, and 510(k)/De Novo submission support — engineered so the software is defensible to a reviewer, not just functional for a user.
A model that predicts well but can't produce a traceable design history file stalls in review. Real SaMD risk lives in the development record: requirements traceability, verification evidence, and a risk file that maps every hazard to a mitigation.
We run full IEC 62304 software lifecycle processes from day one — requirements, architecture, verification, and risk management under ISO 14971 — so the design history file is a byproduct of how we build, not a document assembled afterward.
Clients move through 510(k) and De Novo review without documentation deficiencies. Design history files, risk management files, and verification records are complete, traceable, and current.
IMDRF risk-based classification, predicate analysis, and a submission pathway (510(k), De Novo, PMA) mapped before a line of code ships.
Software requirements, architecture, and unit-level design controlled under a documented IEC 62304 process, with traceability from requirement to test.
Hazard analysis, risk controls, and a risk management file that maps every identified hazard to a verified mitigation.
Clinical validation studies and usability evaluation under IEC 62366, designed to generate the evidence a submission actually needs.
Submission packages assembled and reviewed against FDA guidance, with responses to additional information requests handled directly.
Complaint handling, adverse event tracking, and post-market clinical follow-up built into the software's operational lifecycle.